Laboratory Corporation of America Holdings (0JSY.L)
| Previous close | 244.66 |
| Open | 245.95 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 243.82 - 245.95 |
| 52-week range | 243.82 - 245.95 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 24.178B |
| Beta (5Y monthly) | 1.04 |
| PE ratio (TTM) | 11.19 |
| EPS (TTM) | 21.78 |
| Earnings date | 27 Jul 2022 - 01 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Labcorp Launches New Test for People With Skin Cancer
BURLINGTON, N.C., May 18, 2022--Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company. The new test measures Lymphocyte-activation gene 3 (LAG-3) expression levels by immunohistochemistry (IHC) in tumor tissue. LAG-3 is an immune-oncology target with demonstrable clinical benefit in patients with melanoma. The test is available for use in both clinical trials and for the care and treatment of patien
- Business Wire
Labcorp Receives Emergency Use Authorization for First Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection
BURLINGTON, N.C., May 18, 2022--Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection kit available that simultaneously detects COVID-19, influenza A/B and respiratory syncytial virus (RSV), a common but contagious respiratory virus often seen in children.
- Business Wire
Labcorp to Speak at the UBS 2022 Global Healthcare Conference
BURLINGTON, N.C., May 17, 2022--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the UBS 2022 Global Healthcare Conference on Tuesday, May 24 at 2:45 p.m. ET.
